Bisphenol A exposure disrupts the circadian clock system and impairs glycolipid metabolic function in mice liver

Hao Dong1, Wenli Ding1, Bonan Xiao1

  • 1Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, 712100, Shaanxi, China; Key Laboratory of Animal Biotechnology of the Ministry of Agriculture and Rural Affairs, Northwest A&F University, Yangling, 712100, Shaanxi, China.

Insights

Bisphenol A (BPA) disrupts the body's internal clock and impairs liver metabolism. This endocrine-disrupting chemical exposure leads to metabolic disorders in mice and liver cells, highlighting environmental health risks.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Chronobiology

Background:

  • Bisphenol A (BPA) is an endocrine-disrupting chemical linked to metabolic disorders.
  • Previous research indicates BPA affects liver glucose and lipid metabolism, but mechanisms are unclear.
  • The role of circadian clock disruption in BPA-induced metabolic issues requires further investigation.

Purpose of the Study:

  • To investigate the effects of BPA on liver glucose and lipid metabolism.
  • To determine the association between BPA exposure and circadian clock disruption in mouse hepatocytes and in vivo models.
  • To elucidate the molecular mechanisms underlying BPA-induced metabolic disorders.

Main Methods:

  • In vitro studies using mouse hepatocytes (AML12) exposed to BPA.
  • In vivo studies using ICR mice exposed to BPA.
  • Analysis of gene and protein expression related to circadian rhythm and glucose/lipid metabolism (e.g., BMAL1, Nr1d1, Dbp, Cd36, Glut2, Hmgcr, Pparα, Srebp1c, Elovl6).
  • Assessment of glucose tolerance, insulin sensitivity, and liver glycogen/triglyceride levels in mice.

Main Results:

  • BPA exposure altered circadian clock gene expression (BMAL1, Nr1d1, Dbp) in AML12 cells.
  • BPA affected glucose and lipid metabolism genes (Cd36, Glut2, Hmgcr, Pparα) in hepatocytes.
  • In vivo, BPA exposure impaired glucose tolerance, reduced insulin sensitivity, increased liver glycogen, and altered lipid metabolism markers.
  • BPA exposure increased Nr1d1 and Cd36 mRNA, while decreasing Srebp1c and Elovl6 mRNA in mouse liver.

Conclusions:

  • BPA exposure disrupts the circadian clock system and impairs liver glucose and lipid metabolism.
  • Environmental BPA overload can contribute to metabolic disorders in mammals.
  • The circadian clock system may play a regulatory role in BPA-induced liver metabolic disorders, indicating potential health risks.

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.8K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
488
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
889
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266